Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…y signals. These preliminary data support further evaluation of ruxolitinib as an adjunctive therapy for severe CIP. ClinicalTrials.gov Ide…
…tudy was conducted including all patients with MPN treated with ruxolitinib. Demographic, clinical, and disease evolution variables were co…
… kinase (JAK) – STAT signalling in PSM pathogenesis, suggesting ruxolitinib, a JAK 1/2 inhibitor, as potential therapeutic option [N Engl J…
…allogeneic haematopoietic stem cell transplantation(allo-HSCT). Ruxolitinib is effective in refractory cases, but real-world safety data ar…
… M, PHan V, Weinberg JB, Palmares TM, Song A, Lee S, Mortara L. Ruxolitinib in treatment of refractory hypereosinophilic syndrome. Journal …
…ory values. The patient was then discharged on a stable dose of ruxolitinib, anakinra and prednisone. This case illustrates the therapeutic…
…imicrobials and high-dose steroids provided only brief control. Ruxolitinib followed by subcutaneous azacitidine stabilised inflammatory ma…
…s-matched umbilical cord blood transplant, with ciclosporin and mycophenolate mofetil as GvHD prophylaxis. Post-transplant, he developed grade 3 skin…
…kaemia (n=2), myelodysplastic syndrome (n=2), and others (n=4). Vedolizumab was used as third-line therapy in seven patients, fourth-line i…
…Objectives To determine the safety and efficacy of ruxolitinib (RUX) and fostamatinib (FOS) compared with standard of care (SO…
…ock IFN and PRR signaling through 3-week ex vivo treatment with Ruxolitinib and Cmpd1,6 inhibitors of JAK1/2 (downstream of IFN) and TBK1(d…
…Background Cryptococcal meningitis associated with ruxolitinib use in patients with myelofibrosis is rare. Furthermore, concom…